Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr₹776 Cr

What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLENMARK PHARMACEUTICALS is ₹-1,502 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-1,502 Cr
Mar2024₹297 Cr
Mar2023₹942 Cr
Mar2022₹970 Cr
Mar2021₹776 Cr

How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-1,502 Cr
Negative
Mar2024 ₹297 Cr
-68.44
Mar2023 ₹942 Cr
-2.92
Mar2022 ₹970 Cr
25.01
Mar2021 ₹776 Cr -

Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,201.7 Cr 2.2% 2.4% 45.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.2%

2.4%

45.4%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses